Skip to content

The Effects of Escloramfetamine and Dexmedetomidine on Maternal Blood Loss and Hemodynamic Parameters During Cesarean Section

The Effects of Escloramfetamine and Dexmedetomidine on Maternal Blood Loss and Hemodynamic Parameters During Cesarean Section

Status
Recruiting
Phases
Unknown
Study type
Interventional
Source
ChiCTR
Registry ID
ChiCTR2500107563
Enrollment
Unknown
Registered
2025-08-14
Start date
2024-11-07
Completion date
Unknown
Last updated
2025-08-18

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Blood loss during cesarean section

Interventions

Ketamine group:After delivery of the fetus and cutting of the umbilical cord, immediately administer an intravenous infusion of 0.20 mg/kg of esketamine.
Dexmedetomidine Group:Immediately after delivery of the fetus and cutting of the umbilical cord, administer an intravenous infusion of 0.2 µg/kg of dexmedetomidine.
control group:After delivery of the fetus and cutting of the umbilical cord, immediately administer the same amount of saline solution at the same rate.

Sponsors

The Third Affiliated Hospital of ZhengZhou University
Lead Sponsor

Eligibility

Sex/Gender
Female
Age
20 Years to 40 Years

Inclusion criteria

Inclusion criteria: (1) American Society of Anesthesiologists (ASA) physical status classification II; (2) Age between 20 and 40 years old; (3) Pregnancy between 37 and 42 weeks; (4) Body mass index (BMI) <= 35 kg/m^2.

Exclusion criteria

Exclusion criteria: (1) Emergency cesarean section; (2) Contraindications for spinal anesthesia (coagulation disorders, lumbar disc herniation, spinal deformities, or history of spinal surgery); (3) Twin pregnancy; (4) Allergy to a2-adrenergic agonists or opioid medications; (5) Preoperative use of analgesics or sedatives; (6) Inability to understand the various scales used in this trial; (7) Neurological or psychiatric disorders; or (8) Enrollment in other clinical trials.

Design outcomes

Primary

MeasureTime frame
Amount of bleeding;Postoperative bleeding volume within 24 hours;Systolic blood pressure/diastolic blood pressure;heart rate;mean arterial pressure;platelet;

Secondary

MeasureTime frame
Restore quality;anxious and depressed state;Postoperative analgesic effect;Hb;white blood cell ;neutrophil;lymphocyte;monocyte;CRP;incidence of adverse reactions;

Countries

China

Contacts

Public ContactTao Wang

The Third Affiliated Hospital of ZhengZhou University

dengcy2000@163.com+86 137 3318 8632

Outcome results

None listed

Source: ChiCTR (via WHO ICTRP) · Data processed: Feb 4, 2026